title: Cefoxitin in the treatment of aerobic and anaerobic infections. Prospective correlation of in vitro susceptibility methods with clinical outcome.
abstract: Anaerobic isolates from patients with intra-abdominal infection were tested in vitro by eight methods for susceptibility to cefoxitin. Broth disk elution correlated poorly with clinical outcome. The clinical breakpoint for anaerobic susceptibility to cefoxitin was less than or equal to 32 micrograms/ml.
authors.affiliation: University of California, Los Angeles, School of Medicine.
authors.forename: E J
authors.initials: EJ
authors.lastname: Goldstein
authors.forename: D M
authors.initials: DM
authors.lastname: Citron
authors.forename: R E
authors.initials: RE
authors.lastname: Cole
authors.forename: D M
authors.initials: DM
authors.lastname: Rangel
authors.forename: A S
authors.initials: AS
authors.lastname: Seid
authors.forename: M O
authors.initials: MO
authors.lastname: Ostovari
mesh_terms: D000328:Adult; D000368:Aged; D001420:Bacteria, Aerobic / Q000187:drug effects*; D001421:Bacteria, Anaerobic / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002440:Cefoxitin / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests / Q000379:methods; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care
chemical_list: D002440:Cefoxitin